Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04754087 · ClinicalTrials.gov registry record · NA

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

A NA study of Osteoarthritis, Hip and Total Hip Arthroplasty, sponsored by Zimmer Biomet.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
11
Study locations

NCT04754087 is a NA study of Osteoarthritis, Hip and Total Hip Arthroplasty that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 300 participants, below the 1,258-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (76% lower). The trial reports 11 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04754087, a NA study of Osteoarthritis, Hip and Total Hip Arthroplasty, is actively recruiting participants, sponsored by Zimmer Biomet.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
11
Study locations

Study Summary

The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.

Conditions Studied

Osteoarthritis, Hip Total Hip Arthroplasty Avascular Necrosis of Hip Degenerative Joint Disease of Hip Rheumatoid Arthritis of Hip Osteoarthritis of Hip Fractures, Hip Fracture of Hip

Interventions

  • DEVICE Vivacit-E and Longevity (HXLPE) Liners

Study Locations (11)

Other

  • Copenhagen University Hospital Hvidovre - Hvidovre
  • Zuyderland Hospital - Geleen
  • OCON Hengelo - Hengelo
  • Skane University Hospital - Lund

Oregon

  • Slocum Center for Orthopedics & Sports Medicine - Eugene
  • Oregon Health and Science University - Portland

Colorado

  • Colorado Joint Replacement - Denver

Indiana

  • South Bend Orthopaedics - South Bend

North Carolina

  • Duke University Medical Center - Durham

Utah

  • University of Utah Health - Salt Lake City

UK

  • The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Royal Bournemouth Hospital - Bournemouth

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2021-07-07
Est. Completion 2033-12-31
Phase NA

Sponsor

Zimmer Biomet

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04754087

The ClinicalTrials.gov registry entry for NCT04754087 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,258-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (76% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention - of which Vivacit-E and Longevity (HXLPE) Liners is the first listed.

NCT04754087 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Other, Oregon, Colorado.

Frequently Asked Questions

What is clinical trial NCT04754087 about?

NCT04754087 is a clinical study titled "G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study". The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.

What is the current status of trial NCT04754087?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-07-07. Estimated completion is 2033-12-31.

What conditions does trial NCT04754087 study?

This clinical trial studies the following conditions: Osteoarthritis, Hip, Total Hip Arthroplasty, Avascular Necrosis of Hip, Degenerative Joint Disease of Hip, Rheumatoid Arthritis of Hip.

What interventions are being tested in trial NCT04754087?

The interventions under investigation include: Vivacit-E and Longevity (HXLPE) Liners (DEVICE).

Who is sponsoring clinical trial NCT04754087?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04754087 being conducted?

This trial has 11 study locations across Colorado, Indiana, North Carolina, Oregon, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoarthritis, Hip

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Osteoarthritis, Hip

All registered trials for this condition

Total Hip Arthroplasty

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.